Bull World Health Organ. 1983;61(3):383-94.
The development of antimicrobial drugs, and particularly of antibiotics, has played a considerable role in substantially reducing the morbidity and mortality rates of many infectious diseases. However, the fact that bacteria can develop resistance to antibiotics has produced a situation where antimicrobial agents are losing their effectiveness because of the spread and persistence of drug-resistant organisms. To combat this, more and more antibiotics with increased therapeutic and prophylactic action will need to be developed.This article is concerned with antibiotic resistance in bacteria which are pathogenic to man and animals. The historical background is given, as well as some information on the present situation and trends of antibiotic resistance to certain bacteria in different parts of the world. Considerable concern is raised over the use of antibiotics in man and animals. It is stated that antibiotic resistance in human pathogens is widely attributed to the "misuse" of antibiotics for treatment and prophylaxis in man and to the administration of antibiotics to animals for a variety of purposes (growth promotion, prophylaxis, or therapy), leading to the accumulation of resistant bacteria in their flora. Factors favouring the development of resistance are discussed.
抗菌药物,尤其是抗生素的研发,在大幅降低许多传染病的发病率和死亡率方面发挥了重要作用。然而,细菌会对抗生素产生耐药性这一事实导致了一种情况,即由于耐药生物体的传播和持续存在,抗菌药物正逐渐失去效力。为应对这一问题,需要研发越来越多具有更强治疗和预防作用的抗生素。本文关注的是对人和动物致病的细菌中的抗生素耐药性。文中给出了历史背景,以及世界各地某些细菌对抗生素耐药性的现状和趋势的一些信息。人们对人和动物使用抗生素深感担忧。据称,人类病原体中的抗生素耐药性广泛归因于在人类治疗和预防中“滥用”抗生素,以及出于各种目的(促进生长、预防或治疗)给动物使用抗生素,导致其菌群中耐药细菌的积累。文中还讨论了有利于耐药性发展的因素。